Basic Information
RNALocate ID: RLID:11002578
RNA Symbol: hsa-miR-328-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-328
RNA ID: miRBase:MIMAT0000752
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 19002258
Tissue/Cell Line: Peripheral blood mononuclear cells
Method: qPCR
Description: Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002051 Mitochondrion HeLa cells 27396686
RLID:01002052 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002577 Exosome Serum 18589210
RLID:11002579 Exosome Renal cancer cells 21670082
RLID:11002580 Exosome Brain tissue 23382797
RLID:11002581 Exosome Plasma 23663360
RLID:11002582 Extracellular vesicle HEK-293T cells 22849433
RLID:11002583 Microvesicle Seminal plasma 23539611
RLID-D:11000128 Exosome Blood
RLID-D:11000429 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-328-3p Diffuse large b cell lymphoma MNDR-E-MI-40309
MNDR hsa-miR-328-3p Oral squamous cell carcinoma MNDR-E-MI-40310
MNDR hsa-miR-328-3p Medulloblastoma MNDR-E-MI-40311
MNDR hsa-miR-328-3p High-grade serous ovarian carcinoma MNDR-E-MI-40312
MNDR hsa-miR-328-3p Ovarian clear cell carcinoma MNDR-E-MI-40313
MNDR hsa-miR-328-3p Uterine corpus endometrial carcinoma MNDR-E-MI-40314
MNDR hsa-miR-328-3p Estrogen-receptor positive breast cancer MNDR-E-MI-40315
MNDR hsa-miR-328-3p Estrogen-receptor negative breast cancer MNDR-E-MI-40316
MNDR hsa-miR-328-3p Progesterone-receptor positive breast cancer MNDR-E-MI-40317
MNDR hsa-miR-328-3p Progesterone-receptor negative breast cancer MNDR-E-MI-40318
MNDR hsa-miR-328-3p Her2-receptor positive breast cancer MNDR-E-MI-40319
MNDR hsa-miR-328-3p Breast cancer luminal MNDR-E-MI-40320
MNDR hsa-miR-328-3p Dermatomyositis MNDR-E-MI-40321
MNDR hsa-miR-328-3p Prostate cancer MNDR-E-MI-40322
MNDR hsa-miR-328-3p Gastric cancer MNDR-E-MI-40323
MNDR hsa-miR-328-3p Alzheimer disease MNDR-E-MI-40324
MNDR hsa-miR-328-3p Intracranial aneurysm MNDR-E-MI-40325
MNDR hsa-miR-328-3p Bladder cancer MNDR-E-MI-40326
MNDR hsa-miR-328-3p Esophageal carcinoma MNDR-E-MI-40327
MNDR hsa-miR-328-3p Heart disease MNDR-E-MI-40328
MNDR hsa-miR-328-3p Dysautonomia familial MNDR-E-MI-40329
MNDR hsa-miR-328-3p Myotonic dystrophy MNDR-E-MI-40330
MNDR hsa-miR-328-3p Head and neck cancer MNDR-E-MI-40331
MNDR hsa-miR-328-3p Primary biliary cirrhosis MNDR-E-MI-40332
MNDR hsa-miR-328-3p Leukemia MNDR-E-MI-40333
MNDR hsa-miR-328-3p Huntington disease MNDR-E-MI-40334
MNDR hsa-miR-328-3p Chorea MNDR-E-MI-40335
MNDR hsa-miR-328-3p Lung cancer MNDR-E-MI-40336
MNDR hsa-miR-328-3p Parkinson disease MNDR-E-MI-40337
MNDR hsa-miR-328-3p Breast cancer MNDR-E-MI-40338
MNDR hsa-miR-328-3p Pancreatic cancer MNDR-E-MI-40339
MNDR hsa-miR-328-3p Melanoma MNDR-E-MI-40340
MNDR hsa-miR-328-3p Rectum adenocarcinoma MNDR-E-MI-40341
MNDR hsa-miR-328-3p Nephroblastoma MNDR-E-MI-40342
MNDR hsa-miR-328-3p Colon cancer MNDR-E-MI-40343
MNDR hsa-miR-328-3p Colon adenocarcinoma MNDR-E-MI-40344
MNDR hsa-miR-328-3p Multiple sclerosis MNDR-E-MI-40345
MNDR hsa-miR-328-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-40346
MNDR hsa-miR-328-3p Prostate adenocarcinoma MNDR-E-MI-40347
MNDR hsa-miR-328-3p Carcinoma ductal breast MNDR-E-MI-40348
MNDR hsa-miR-328-3p Glioblastoma MNDR-E-MI-40349
MNDR hsa-miR-328-3p Glioma MNDR-E-MI-40350
MNDR hsa-miR-328-3p Amyotrophic lateral sclerosis MNDR-E-MI-40351
MNDR hsa-miR-328-3p Osteosarcoma MNDR-E-MI-40352
MNDR hsa-miR-328-3p Inclusion body myositis MNDR-E-MI-40353
MNDR hsa-miR-328-3p Infarction middle cerebral artery MNDR-E-MI-40354
MNDR hsa-miR-328-3p Liver cancer MNDR-E-MI-40355
MNDR hsa-miR-328-3p Uterine cancer MNDR-E-MI-40356
MNDR hsa-miR-328-3p Gastric adenocarcinoma MNDR-E-MI-40357
MNDR hsa-miR-328-3p Cervical squamous cell carcinoma MNDR-E-MI-40358
MNDR hsa-miR-328-3p Lung squamous cell carcinoma MNDR-E-MI-40359
MNDR hsa-miR-328-3p Carcinoma lung non-small-cell MNDR-E-MI-40360
MNDR hsa-miR-328-3p Lung adenocarcinoma MNDR-E-MI-40361
MNDR hsa-miR-328-3p Thyroid carcinoma MNDR-E-MI-40362
MNDR hsa-miR-328-3p Ovarian carcinoma MNDR-E-MI-40363
MNDR hsa-miR-328-3p Bladder urothelial carcinoma MNDR-E-MI-40364
MNDR hsa-miR-328-3p Pancreatic adenocarcinoma MNDR-E-MI-40365
MNDR hsa-miR-328-3p Carcinoma renal cell MNDR-E-MI-40366
MNDR hsa-miR-328-3p Kidney renal papillary cell carcinoma MNDR-E-MI-40367
MNDR hsa-miR-328-3p Renal clear cell carcinoma MNDR-E-MI-40368
MNDR hsa-miR-328-3p Cholangiocarcinoma MNDR-E-MI-40369
MNDR hsa-miR-328-3p Esophageal cancer MNDR-E-MI-40370
MNDR hsa-miR-328-3p Lung small cell carcinoma MNDR-E-MI-40371
MNDR hsa-miR-328-3p Breast invasive carcinoma MNDR-E-MI-40372
MNDR hsa-miR-328-3p Hepatocellular carcinoma MNDR-E-MI-40373
MNDR hsa-miR-328-3p Rheumatoid arthritis MNDR-E-MI-40374
MNDR hsa-miR-328-3p Retinoblastoma MNDR-E-MI-40375
MNDR hsa-miR-328-3p Barrett's adenocarcinoma MNDR-E-MI-40376
MNDR hsa-miR-328-3p Hodgkin disease MNDR-E-MI-40377
MNDR hsa-miR-328-3p Burkitt lymphoma MNDR-E-MI-40378
MNDR hsa-miR-328-3p Neuromyelitis optica MNDR-E-MI-40379
MNDR hsa-miR-328-3p Acute myeloid leukemia MNDR-E-MI-40380
MNDR hsa-miR-328-3p Colorectal cancer MNDR-E-MI-40381
MNDR hsa-miR-328-3p Ependymoma MNDR-E-MI-40382
MNDR hsa-miR-328-3p Prostatic neoplasms MNDR-E-MI-40383
MNDR hsa-miR-328-3p Barrett's carcinogenesis MNDR-E-MI-40384
MNDR hsa-miR-328-3p Breast cancer her3+ negative MNDR-E-MI-40385
MNDR hsa-miR-328-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-40386
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCG2 Homo sapiens RR00024748
TOP